BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 16, 1999
View Archived Issues
Maxamine advances in phase II and III trials during Q2 1999
Read More
Aastrom Biosciences enters distribution agreements for Norway and Switzerland
Read More
Cell Therapeutics advances oncology portfolio in Q2 1999
Read More
CpG ImmunoPharmaceuticals obtains financing for additional clinical trials
Read More
Immune Complex Corporation awarded SBIR contract to detect cytochrome P450 polymorphisms
Read More
NIH initiates interstitial cystitis trial
Read More
Iomed begins phase III trials of IontoDex for inflammation
Read More
ACES will evaluate azithromycin in heart disease
Read More
GlycoDesign to acquire Vascular Therapeutics
Read More
NexMed reports results from multiple-use study of topical alprostadil cream
Read More
ImClone Systems initiates phase II C225/cisplatin trial
Read More
Nexell launches first product from Cytonex diagnostic line
Read More
AdProTech reaches C3d adjuvant licensing agreement with University of Cambridge
Read More
Tyrosine kinase inhibitors potentially useful for patient-specific treatment of tumors
Read More
Triazepinone compounds from Merck KGaA act as AGE formation inhibitors
Read More
Creative BioMolecules, NeoGenesis team up to identify new drugs to treat degenerative disorders
Read More
Leading BPH treatment to be copromoted by Abbott and Boehringer Ingelheim
Read More
5-HT1A receptor agonist LB-50016, a novel putative anxiolytic and antidepressant
Read More
Antiangiogenic drug ZD-4190 excels in preclinical testing at AstraZeneca
Read More
Merck's newest alphavbeta3 ligands prevent osteoclast-mediated bone resorption
Read More
Centaur researches novel treatments for Alzheimer's disease
Read More
Preclinical study results indicate efficacy of thiazolidinediones in IBD
Read More
Improved NNRTIs reported by Medivir in patent literature
Read More
Cangene receives notification of fast-track status for new anti-chickenpox product
Read More
IL-8 antagonists with broad therapeutic potential synthesized at SmithKline Beecham
Read More
Sanofi-Synthelabo submits MAA for Ditropan XL in the U.K.
Read More
Alusuisse-Lonza announces demerger plans
Read More
Argent gene delivery platform used successfully for sustained, controlled delivery of hGH
Read More
Remune clinical trial commences in South America
Read More
